Deka BioSciences, Inc. is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases.
Location: United States, District of Columbia, Washington
Employees: 11-50
Total raised: $40M
Investors 4
| Date | Name | Website |
| 18.11.2021 | Lumira Ven... | lumiravent... |
| 27.07.2023 | Plains Ven... | plainsvc.c... |
| 26.10.2023 | MPM Capita... | mpmcapital... |
| - | MPM BioImp... | mpmbioimpa... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.09.2023 | - | $20M | - |
| 17.11.2021 | Series A | $20M | - |
Mentions in press and media 7
| Date | Title | Description |
| 18.10.2023 | DC Money Moves: iTech AG lands its largest contract to date with CMS | This editorial article is a part of Biotech Month of Technical.ly’s editorial calendar. Money Moves is a column where we chart the raises, mergers and other funding news of tech companies across the region on the third Wednesday of the mont... |
| 28.09.2023 | Deka Biosciences Closes USD $20M Series B2 Financing | Deka Biosciences Pre-filled Syringes containing DK2^10 (EGFR) Deka Biosciences, a Germantown, MD-based biotech company, raised USD $20M in Series B2 funding. The round was led by MPM BioImpact, with participation from Leaps by Bayer, O-Bio ... |
| 28.09.2023 | Deka Biosciences Completes $20M Series B2 | GERMANTOWN, MD, Biotech company Deka Biosciences today announced that it has successfully closed a $20 Million Series B2 financing round. >> Click here for more funding data on Deka Biosciences >> To export Deka Biosciences ... |
| 28.09.2023 | Deka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact | Sept. 28, 2023 — Maryland-based biotech company Deka Biosciences (“Deka”) today announced that it has successfully closed a USD $20 Million Series B2 financing with a syndicate of life science investors led by MPM BioImpact, and joined by a... |
| 17.11.2021 | Deka Biosciences Raises USD 20M in Series A Funding | Deka Biosciences, a Germantown, MD-based biotech company, raised USD20M in Series A funding. The round was led by Leaps by Bayer and Lumira Ventures with participation from O-Bio (Echo Investment Capital), Viva BioInnovator and Alexandria V... |
| 16.11.2021 | Deka Biosciences Raises USD 20 Million in Series A Financing | GERMANTOWN, Md., Nov. 16, 2021 /PRNewswire/ -- Maryland-based biotech company Deka Biosciences ("Deka") today announced that it has successfully closed a USD 20 Million Series A financing with a syndicate of life science investors... |
| 16.11.2021 | Deka Biosciences Raises $20 Million in Series A Financing | Maryland-based biotech company Deka Biosciences (“Deka”) today announced that it has successfully closed a USD 20 Million Series A financing with a syndicate of life science investors led by Leaps by Bayer, the impact investment arm of Baye... |